Content area
Full Text
About the Authors:
Steven G. Deeks
* E-mail: [email protected]
Affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America
ORCID http://orcid.org/0000-0001-6371-747X
Sharon R. Lewin
Affiliations Peter Doherty Institute of Infection and Immunity, University of Melbourne, and Royal Melbourne Hospital, Melbourne, Australia, Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia
Linda-Gail Bekker
Affiliation: Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South AfricaCitation: Deeks SG, Lewin SR, Bekker L-G (2017) The end of HIV: Still a very long way to go, but progress continues. PLoS Med 14(11): e1002466. https://doi.org/10.1371/journal.pmed.1002466
Published: November 30, 2017
Copyright: © 2017 Deeks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this work.
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: SD is an advisor to InnaVirVax, Bionor Pharma and Bryologix and receives grant support from Gilead, Merck and ViiV. SL’s institution has received funding for investigator-initiated industry-sponsored studies from Merck, Gilead, Viiv Healthcare and Tetralogic and has also acted on the advisory board for and as consultancy to Callimune, Tetralogic, and InnaVirVax. LGB is employed by the Desmond Tutu HIV Centre, UCT and the Desmond Tutu HIV Foundation. She has received honoraria for technical inputs from Jansen and Merck in the last 5 years and her organisation has benefited from grants from Gilead, Merck and ViiV. SD, SL, and LGB served as guest editors on PLOS Medicine’s Special Issue on Advances in HIV Prevention, Treatment and Cure.
Abbreviations: ART, antiretroviral therapy; BNAb, broadly neutralizing antibody; MSM, men who have sex with men
Provenance: Commissioned; not externally peer reviewed.
Let’s End It is the theme of this year’s World AIDS Day, which falls on December 1. In the spirit of the event, PLOS Medicine is devoting this special issue to a discussion on advances in HIV prevention, treatment, and cure. Here, we describe many of the remaining barriers in ending the epidemic and highlight a number of accompanying studies that provide paths forward for...